PAb-W4

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePAb-W4
Drug Alias Nameanti-TGase II (Quark)anti-TGase II antibody (Quark)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTransglutaminases inhibitors
TargetsTransglutaminases
Therapy Area/IndicationsRenal InsufficiencyDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesQuark Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQuark Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRenal InsufficiencyDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksN/A